Related Experiment Videos
New techniques for percutaneous renal revascularization: atherectomy and stenting
1Department of Vascular Medicine, Cleveland Clinic Foundation, Ohio.
The Urologic Clinics of North America
|May 1, 1994
Summary
Percutaneous transluminal renal angioplasty (PTRA) risks re-stenosis. Renal artery stenting shows promise for better long-term results, but more trials are needed to confirm its superiority over PTRA.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Vascular Surgery
Background:
- Percutaneous transluminal renal angioplasty (PTRA) is a common treatment for renal artery stenosis.
- Current PTRA techniques carry a risk of re-stenosis, often due to intimal hyperplasia.
- Advances in interventional cardiology necessitate re-evaluation of treatment options.
Purpose of the Study:
- To compare the long-term efficacy of renal artery stenting versus PTRA.
- To identify optimal candidates for surgical revascularization or endovascular procedures.
- To assess the potential of renal artery stenting to overcome PTRA limitations.
Main Methods:
- Review of available data on PTRA and renal artery stenting outcomes.
- Analysis of patient selection criteria for different revascularization techniques.
- Discussion of technical aspects influencing the success of renal artery stenting.
Main Results:
- Renal artery stenting represents significant progress in treating renal artery stenosis.
- Adequate sizing and positioning of stents are crucial for optimal outcomes.
- Data suggest stenting may offer superior long-term results compared to PTRA.
Conclusions:
- Renal artery stenting is a promising alternative to PTRA, potentially offering better long-term results.
- Further randomized controlled trials are essential to definitively establish the superiority of stenting over PTRA.
- Careful patient selection and procedural technique are paramount for successful renal artery revascularization.